IDEXX Laboratories, Inc. (LON:0J8P)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 37.85B |
| Revenue (ttm) | 2.95B |
| Net Income (ttm) | 719.43M |
| Shares Out | n/a |
| EPS (ttm) | 8.77 |
| PE Ratio | 52.61 |
| Forward PE | 48.18 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 144 |
| Average Volume | 277 |
| Open | 630.01 |
| Previous Close | 644.43 |
| Day's Range | 630.01 - 645.27 |
| 52-Week Range | 351.94 - 687.50 |
| Beta | 1.56 |
| RSI | 52.70 |
| Earnings Date | Nov 3, 2025 |
About IDEXX Laboratories
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference... [Read more]
Financial Performance
In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.
Financial numbers in USD Financial StatementsNews
IDEXX Laboratories Inc (IDXX) to Participate in Morgan Stanley Global Healthcare Conference | ...
IDEXX Laboratories Inc (IDXX) to Participate in Morgan Stanley Global Healthcare Conference | IDXX stock news
IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and ...
Options Exercise: M. Anne Szostak At IDEXX Laboratories Realizes $951K
Highlighted on August 26, it was unveiled in an SEC filing that Szostak, Board Member at IDEXX Laboratories (NASDAQ: IDXX), executed a significant transaction involving the exercise of company stock ...
Insider Selling: Michael G Erickson Unloads $263K Of IDEXX Laboratories Stock
Making a noteworthy insider sell on August 14, Michael G Erickson , Executive Vice President at IDEXX Laboratories (NASDAQ: IDXX), is reported in the latest SEC filing. What Happened: Erickson's deci...
$1000 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth This Much Today
IDEXX Laboratories (NASDAQ: IDXX) has outperformed the market over the past 15 years by 10.61% on an annualized basis producing an average annual return of 23.26%. Currently, IDEXX Laboratories has a...
A Closer Look at IDEXX Laboratories's Options Market Dynamics
Whales with a lot of money to spend have taken a noticeably bearish stance on IDEXX Laboratories . Looking at options history for IDEXX Laboratories (NASDAQ: IDXX) we detected 8 trades. If we conside...
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...
Is the Market Bullish or Bearish on IDEXX Laboratories?
IDEXX Laboratories's (NYSE: IDXX) short percent of float has risen 3.9% since its last report. The company recently reported that it has 2.64 million shares sold short , which is 4.26% of all regular...
Tesla, Delta Air, IDEXX Laboratories And More On CNBC's 'Final Trades'
In a volatile market landscape marked by rapid shifts in investor sentiment, financial experts are spotlighting key stocks and sectors poised for growth. On CNBC's “ Halftime Report Final Trades ,” Br...
S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes
Major U.S. equities indexes pushed higher at the top of the new trading week, bouncing back from declines posted ahead of the weekend. Although weaker-than-expected jobs data released on Friday raised...
IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript
Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF
The Investment Committee gives you their top stocks to watch for the second half.
Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More
U.S. equities were higher at midday, bouncing back from Friday's employment report-related selloff, and on news the European Union would delay new tariffs on U.S. goods. The Dow Jones Industrial Avera...
Here's How Much $1000 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today
IDEXX Laboratories (NASDAQ: IDXX) has outperformed the market over the past 20 years by 4.25% on an annualized basis producing an average annual return of 12.73%. Currently, IDEXX Laboratories has a ...
Wayfair, CommScope Holding, Steelcase, IDEXX Laboratories And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Monday. Shares of Wayfair Inc . (NYSE: W) rose sharply during Monday's session following better-than-expected second-qua...
IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation
Pet healthcare is witnessing a surge in demand as more households prioritize their pets’ well-being, driving companies in this sector to outperform expectations. This trend is reflected in IDEXX Labor...
IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation
Pet healthcare is witnessing a surge in demand as more households prioritize their pets' well-being, driving companies in this sector to outperform expectations. This trend is reflected in IDEXX Labor...
How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs
Idexx Laboratories easily beat second-quarter expectations Monday as the animal-health player benefits from the "puppy boom" of 2020.
Earnings Summary: IDEXX Q2 2025 profit rises on higher revenues
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leading pet healthcare company, on Monday reported an increase in revenue and net income for the second quarter of fiscal 2025. Second-quarter revenue increa...
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2212289374-64be8a37ce6b42c8b7298c8074118732.jpg)
IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook
Shares of IDEXX Laboratories soared more than 10% in premarket trading Monday after the pet health care company reported better-than-expected second-quarter results and raised its 2025 profit and reve...
IDEXX Laboratories raises annual forecasts on strong demand for pet diagnostics
IDEXX Laboratories raised its full-year profit and revenue forecasts on Monday after reporting better-than-expected second-quarter results, driven by strong demand for its veterinary diagnostic equipm...
Idexx (IDXX) Q2 Revenue Jumps 11%
IDEXX Laboratories Non-GAAP EPS of $3.50 beats by $0.20, revenue of $1.11B beats by $40M
IDEXX Laboratories Announces Second Quarter Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results. “Our innovation-driven strategy delive...